Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BVSNASDAQ:BWAYNASDAQ:IRMDNASDAQ:SIBN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBVSBioventus$7.43-2.9%$8.95$3.90▼$14.38$608.84M0.92449,684 shs350,667 shsBWAYBrainsWay$8.95-2.8%$9.30$4.80▼$11.79$166.99M1.1772,643 shs33,713 shsIRMDIradimed$53.02-0.6%$52.54$40.55▼$63.29$674.15M0.8244,452 shs24,675 shsSIBNSI-BONE$14.47+0.4%$14.93$11.70▼$19.16$614.30M1.02360,732 shs277,689 shs20 Stocks to Sell NowGet This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBVSBioventus-2.88%-0.93%-17.72%-28.69%+86.68%BWAYBrainsWay-2.82%+13.87%-3.76%-17.05%+88.03%IRMDIradimed-0.56%+4.41%+1.16%-12.65%+26.66%SIBNSI-BONE+0.42%+7.58%+3.06%-12.62%-0.69%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBVSBioventus3.2649 of 5 stars3.30.00.00.02.94.21.3BWAYBrainsWay3.2275 of 5 stars3.53.00.00.03.50.81.9IRMDIradimed4.8343 of 5 stars3.52.02.54.43.43.31.9SIBNSI-BONE4.1694 of 5 stars3.53.00.03.33.22.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBVSBioventus 2.67Moderate Buy$15.00101.88% UpsideBWAYBrainsWay 3.00Buy$13.1747.11% UpsideIRMDIradimed 3.00Buy$72.0035.80% UpsideSIBNSI-BONE 3.00Buy$24.4068.62% UpsideCurrent Analyst Ratings BreakdownLatest BWAY, IRMD, SIBN, and BVS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/17/2025BVSBioventusCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$15.00 ➝ $15.003/12/2025BWAYBrainsWayHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.00 ➝ $16.002/25/2025SIBNSI-BONETruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$18.00 ➝ $22.002/25/2025SIBNSI-BONECantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$25.00 ➝ $25.002/25/2025SIBNSI-BONENeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$20.00 ➝ $24.002/14/2025IRMDIradimedRoth MkmSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$60.00 ➝ $72.00(Data available from 4/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBVSBioventus$573.28M1.06$0.59 per share12.58$2.80 per share2.65BWAYBrainsWay$41.02M4.12N/AN/A$2.50 per share3.58IRMDIradimed$73.24M9.20$1.32 per share40.12$5.66 per share9.37SIBNSI-BONE$167.18M3.67N/AN/A$4.18 per share3.46Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBVSBioventus-$156.23M-$0.51N/A16.15N/A-7.11%15.61%4.01%N/ABWAYBrainsWay-$4.20M$0.1789.5155.94N/A3.88%3.52%2.26%5/6/2025 (Estimated)IRMDIradimed$19.23M$1.5035.3526.51N/A26.26%24.12%21.20%5/1/2025 (Estimated)SIBNSI-BONE-$43.34M-$0.76N/AN/AN/A-23.82%-22.51%-16.53%5/5/2025 (Estimated)Latest BWAY, IRMD, SIBN, and BVS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025BWAYBrainsWay$0.02N/AN/AN/A$11.45 millionN/A5/5/2025Q1 2025SIBNSI-BONE-$0.24N/AN/AN/A$45.13 millionN/A5/1/2025Q1 2025IRMDIradimed$0.43N/AN/AN/A$19.33 millionN/A2/24/2025Q4 2024SIBNSI-BONE-$0.16-$0.11+$0.05-$0.11$48.87 million$49.00 million2/13/2025Q4 2024IRMDIradimed$0.45$0.40-$0.05$0.40$19.09 million$19.39 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBVSBioventusN/AN/AN/AN/AN/ABWAYBrainsWayN/AN/AN/AN/AN/AIRMDIradimed$0.681.28%N/A45.33%N/ASIBNSI-BONEN/AN/AN/AN/AN/ALatest BWAY, IRMD, SIBN, and BVS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/6/2025IRMDIradimedquarterly$0.171.1%2/24/20252/24/20253/5/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBVSBioventus1.851.410.99BWAYBrainsWayN/A4.524.23IRMDIradimedN/A9.217.82SIBNSI-BONE0.228.257.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBVSBioventus62.94%BWAYBrainsWay30.11%IRMDIradimed92.34%SIBNSI-BONE98.11%Insider OwnershipCompanyInsider OwnershipBVSBioventus32.90%BWAYBrainsWay19.00%IRMDIradimed37.10%SIBNSI-BONE3.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBVSBioventus1,20081.94 million54.46 millionNot OptionableBWAYBrainsWay12018.87 million15.24 millionNot OptionableIRMDIradimed11012.72 million7.97 millionOptionableSIBNSI-BONE35042.45 million40.30 millionOptionableBWAY, IRMD, SIBN, and BVS HeadlinesRecent News About These CompaniesMarshall Wace LLP Has $3.71 Million Stock Position in SI-BONE, Inc. (NASDAQ:SIBN)April 28 at 4:11 AM | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) Shares Sold by Russell Investments Group Ltd.April 27 at 3:26 AM | marketbeat.comJPMorgan Chase & Co. Acquires 102,660 Shares of SI-BONE, Inc. (NASDAQ:SIBN)April 22, 2025 | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) Shares Sold by Champlain Investment Partners LLCApril 20, 2025 | marketbeat.comSI-BONE (NASDAQ:SIBN) Shares Gap Up - What's Next?April 17, 2025 | marketbeat.comSI-BONE (NASDAQ:SIBN) Shares Down 4.5% - Time to Sell?April 16, 2025 | marketbeat.comTrexquant Investment LP Invests $1.23 Million in SI-BONE, Inc. (NASDAQ:SIBN)April 13, 2025 | marketbeat.comWellington Management Group LLP Lowers Position in SI-BONE, Inc. (NASDAQ:SIBN)April 13, 2025 | marketbeat.comSI-Bone price target lowered to $20 from $22 at TruistApril 12, 2025 | markets.businessinsider.comSI-BONE’s Sales Accelerated in final 2024 QuarterApril 11, 2025 | ryortho.comSI-BONE, Inc.: Small-cap Developer Of Medical Implants And A Steady Revenue GrowerApril 8, 2025 | seekingalpha.comSI-BONE, Inc. (NASDAQ:SIBN) SVP Sells $44,229.92 in StockApril 6, 2025 | insidertrades.comSI-BONE, Inc. (NASDAQ:SIBN) SVP Michael A. Pisetsky Sells 3,128 SharesApril 6, 2025 | marketbeat.comInsider Selling: SI-BONE, Inc. (NASDAQ:SIBN) Insider Sells 3,311 Shares of StockApril 6, 2025 | marketbeat.comRaymond James Financial Inc. Buys New Shares in SI-BONE, Inc. (NASDAQ:SIBN)April 4, 2025 | marketbeat.comShort Interest in SI-BONE, Inc. (NASDAQ:SIBN) Rises By 40.5%March 31, 2025 | marketbeat.comAmerican Century Companies Inc. Raises Stock Position in SI-BONE, Inc. (NASDAQ:SIBN)March 30, 2025 | marketbeat.comHow SI-BONE, Inc. (NASDAQ:SIBN) Continues to Perform Despite Fluctuating Market SupportMarch 8, 2025 | kalkinemedia.comSI-BONE, Inc. 2024 Q4 - Results - Earnings Call PresentationMarch 4, 2025 | seekingalpha.comQ4 2024 SI-BONE Inc Earnings CallFebruary 26, 2025 | uk.finance.yahoo.comBank of America Securities Reaffirms Their Buy Rating on SI-Bone (SIBN)February 25, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBWAY, IRMD, SIBN, and BVS Company DescriptionsBioventus NYSE:BVS$7.43 -0.22 (-2.88%) Closing price 04/28/2025 04:00 PM EasternExtended Trading$7.42 -0.01 (-0.13%) As of 04/28/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.BrainsWay NASDAQ:BWAY$8.95 -0.26 (-2.82%) Closing price 04/28/2025 04:00 PM EasternExtended Trading$9.16 +0.21 (+2.34%) As of 04/28/2025 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.Iradimed NASDAQ:IRMD$53.02 -0.30 (-0.56%) Closing price 04/28/2025 04:00 PM EasternExtended Trading$53.14 +0.12 (+0.23%) As of 04/28/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.SI-BONE NASDAQ:SIBN$14.47 +0.06 (+0.42%) Closing price 04/28/2025 04:00 PM EasternExtended Trading$14.46 -0.01 (-0.07%) As of 04/28/2025 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Rebounds After Strong Earnings and Buyback Announcement Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret? The Bear Market Has Only Just Started - Here's Why MarketBeat Week in Review – 04/21 - 04/25 3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S. PepsiCo’s Stock Price is Disconnected From Reality: Time to Buy Bears Can Reap Big Benefits With These 3 Short ETF Bets Why Institutions Are Buying Super Micro Computer Stock Again Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
